These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23715967)
1. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Zhang SJ; Hu P; Wang N; Shen Q; Sun AX; Kuang M; Qian GJ Ann Surg Oncol; 2013 Oct; 20(11):3596-602. PubMed ID: 23715967 [TBL] [Abstract][Full Text] [Related]
2. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model. Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Kim JH; Won HJ; Shin YM; Kim PN; Lee SG; Hwang S Eur J Radiol; 2011 Dec; 80(3):e221-5. PubMed ID: 20950977 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985 [TBL] [Abstract][Full Text] [Related]
7. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience. Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155 [TBL] [Abstract][Full Text] [Related]
8. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598 [TBL] [Abstract][Full Text] [Related]
9. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460 [TBL] [Abstract][Full Text] [Related]
10. Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy. Sugo H; Ishizaki Y; Yoshimoto J; Imamura H; Kawasaki S Ann Surg Oncol; 2012 Jul; 19(7):2238-45. PubMed ID: 22302262 [TBL] [Abstract][Full Text] [Related]
11. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246 [TBL] [Abstract][Full Text] [Related]
12. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities. Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764 [TBL] [Abstract][Full Text] [Related]
13. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638 [TBL] [Abstract][Full Text] [Related]
14. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201 [TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases. Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327 [TBL] [Abstract][Full Text] [Related]
19. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133 [TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]